1
项与 CD19/BCMA UCAR-T (Suzhou Maoxing Biotechnology) 相关的临床试验To evaluate the safety and tolerability of CD19-BCMA UCAR-T cell injection in patients with relapsed or refractory multiple myeloma
100 项与 CD19/BCMA UCAR-T (Suzhou Maoxing Biotechnology) 相关的临床结果
100 项与 CD19/BCMA UCAR-T (Suzhou Maoxing Biotechnology) 相关的转化医学
100 项与 CD19/BCMA UCAR-T (Suzhou Maoxing Biotechnology) 相关的专利(医药)
100 项与 CD19/BCMA UCAR-T (Suzhou Maoxing Biotechnology) 相关的药物交易